People who take GLP-1 medications for several years may face a higher risk of developing osteoporosis, gout, and osteomalacia, according to new research presented Monday at the an ...

An estimated 10 million Americans are living with osteoporosis, and another 44 million have low bone density, putting them at increased risk. Despite those numbers, medical experts say the condition ...

New research suggests GLP-1 drugs may increase the risk of bone and tendon injuries and other conditions, including ...

GLP-1s are linked to a higher risk for osteoporosis, gout, and osteomalacia in people with type 2 diabetes and obesity, new research suggests, though an additional study also points to better ...

Approximately 10 million Americans have osteoporosis and another 44 million have low bone density, placing them at increased ...

Osteoporosis is often perceived as a disease that primarily affects older White women, but recent research has uncovered a more nuanced picture, particularly within the Black community. The notion ...

Osteoporosis is the most common bone disease in the U.S., leading to increased risk of fractures and a weakening of bone strength and structure. Now, new guidelines on who should be tested could lead ...

Please provide your email address to receive an email when new articles are posted on . Adults with osteoporosis who received more than one dose of denosumab had a reduced risk for developing diabetes ...